» Articles » PMID: 27845895

Hyaluronan Activates Hyal-2/WWOX/Smad4 Signaling and Causes Bubbling Cell Death when the Signaling Complex is Overexpressed

Overview
Journal Oncotarget
Specialty Oncology
Date 2016 Nov 16
PMID 27845895
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Malignant cancer cells frequently secrete significant amounts of transforming growth factor beta (TGF-β), hyaluronan (HA) and hyaluronidases to facilitate metastasizing to target organs. In a non-canonical signaling, TGF-β binds membrane hyaluronidase Hyal-2 for recruiting tumor suppressors WWOX and Smad4, and the resulting Hyal-2/WWOX/Smad4 complex is accumulated in the nucleus to enhance SMAD-promoter dependent transcriptional activity. Yeast two-hybrid analysis showed that WWOX acts as a bridge to bind both Hyal-2 and Smad4. When WWOX-expressing cells were stimulated with high molecular weight HA, an increased formation of endogenous Hyal-2/WWOX/Smad4 complex occurred rapidly, followed by relocating to the nuclei in 20-40 min. In WWOX-deficient cells, HA failed to induce Smad2/3/4 relocation to the nucleus. To prove the signaling event, we designed a real time tri-molecular FRET analysis and revealed that HA induces the signaling pathway from ectopic Smad4 to WWOX and finally to p53, as well as from Smad4 to Hyal-2 and then to WWOX. An increased binding of the Smad4/Hyal-2/WWOX complex occurs with time in the nucleus that leads to bubbling cell death. In contrast, HA increases the binding of Smad4/WWOX/p53, which causes membrane blebbing but without cell death. In traumatic brain injury-induced neuronal death, the Hyal-2/WWOX complex was accumulated in the apoptotic nuclei of neurons in the rat brains in 24 hr post injury, as determined by immunoelectron microscopy. Together, HA activates the Hyal-2/WWOX/Smad4 signaling and causes bubbling cell death when the signaling complex is overexpressed.

Citing Articles

Dissociation of the nuclear WWOX/TRAF2 switch renders UV/cold shock-mediated nuclear bubbling cell death at low temperatures.

Chen S, Tsai C, Lin S, Lee M, Huang S, Zeng H Cell Commun Signal. 2024; 22(1):505.

PMID: 39420317 PMC: 11487720. DOI: 10.1186/s12964-024-01866-6.


PMF-GRN: a variational inference approach to single-cell gene regulatory network inference using probabilistic matrix factorization.

Skok Gibbs C, Mahmood O, Bonneau R, Cho K Genome Biol. 2024; 25(1):88.

PMID: 38589899 PMC: 11003171. DOI: 10.1186/s13059-024-03226-6.


Zfra Overrides WWOX in Suppressing the Progression of Neurodegeneration.

Chen Y, Liu T, Wen K, Hsu C, Sze C, Chang N Int J Mol Sci. 2024; 25(6).

PMID: 38542478 PMC: 10970703. DOI: 10.3390/ijms25063507.


Hyaluronic Acid as a Modern Approach in Anticancer Therapy-Review.

Michalczyk M, Humeniuk E, Adamczuk G, Korga-Plewko A Int J Mol Sci. 2023; 24(1).

PMID: 36613567 PMC: 9820514. DOI: 10.3390/ijms24010103.


Zfra Inhibits the TRAPPC6AΔ-Initiated Pathway of Neurodegeneration.

Lin Y, Shih Y, Yap Y, Chen Y, Kuo H, Liu T Int J Mol Sci. 2022; 23(23).

PMID: 36498839 PMC: 9739312. DOI: 10.3390/ijms232314510.


References
1.
Lo J, Chou Y, Lai F, Hsu L . Regulation of cell signaling and apoptosis by tumor suppressor WWOX. Exp Biol Med (Maywood). 2015; 240(3):383-91. PMC: 4935227. DOI: 10.1177/1535370214566747. View

2.
Slevin M, Kumar S, Gaffney J . Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses. J Biol Chem. 2002; 277(43):41046-59. DOI: 10.1074/jbc.M109443200. View

3.
Stern R . Devising a pathway for hyaluronan catabolism: are we there yet?. Glycobiology. 2003; 13(12):105R-115R. DOI: 10.1093/glycob/cwg112. View

4.
Bednarek A, Laflin K, Daniel R, Liao Q, Hawkins K, Aldaz C . WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. Cancer Res. 2000; 60(8):2140-5. View

5.
Chang N, Schultz L, Hsu L, Lewis J, Su M, Sze C . 17beta-Estradiol upregulates and activates WOX1/WWOXv1 and WOX2/WWOXv2 in vitro: potential role in cancerous progression of breast and prostate to a premetastatic state in vivo. Oncogene. 2004; 24(4):714-23. DOI: 10.1038/sj.onc.1208124. View